News

3 Reasons GILD is Risky and 1 Stock to Buy Instead

In a sliding market, Gilead Sciences has defied the odds, trading up to $106.42 per share. Its 24% gain since October 2024 has outpaced the S&P 500’s 6.9% drop. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.